A phase II study of dasatinib in the treatment of relapsed or plateau phase multiple myeloma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dasatinib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 29 Aug 2014 Biomarkers information updated
- 23 May 2013 Actual initiation date (Jan 2007) added as reported by ClinicalTrials.gov..
- 04 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.